CPIX News and Press, Cumberland Pharmaceuticals Inc. From 10/20/25

CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO PR Newswire  Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapy NASHVILLE, Tenn. , Oct. 20, 2025 ...

CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC. PR Newswire Premier Membership includes 4,350 U.S. Hospitals NASHVILLE, Tenn. , Oct. 13, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specia...

CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO PR Newswire Injectable Ibuprofen Approved for Treating Pain & Fever NASHVILLE, Tenn. , Oct. 1 , 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceut...

TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA PR Newswire Vibativ ® treats patients with pneumonia and serious skin infections NASHVILLE, Tenn. and RIYADH, Saudi Arabia , Sept. 29, 2025 /P...

2025-08-14 16:15:00 ET Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry's major underlying drivers — higher rates of cancer and chronic disease ...

2025-08-06 01:52:24 ET More on Cumberland Pharmaceuticals Cumberland Pharmaceuticals Inc. (CPIX) Q2 2025 Earnings Call Transcript Cumberland Pharmaceuticals, Inc. (CPIX) Q1 2025 Earnings Call Transcript Financial information for Cumberland Pharmaceuticals R...

2025-08-06 01:52:02 ET Cumberland Pharmaceuticals Inc. (CPIX) Q2 2025 Earnings Conference Call August 05, 2025, 4:30 PM ET Company Participants A. J. Kazimi - Founder, Chairman, President & CEO John Michael Hamm - VP & CFO Todd M. Anthony - Vice President...

2025-08-05 16:46:43 ET More on Cumberland Pharmaceuticals Cumberland Pharmaceuticals, Inc. (CPIX) Q1 2025 Earnings Call Transcript Financial information for Cumberland Pharmaceuticals Read the full article on Seeking Alpha For further details see: Cumberl...

Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date PR Newswire NASHVILLE, Tenn. , Aug. 5, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FD...

SOPHiA GENETICS SA (SOPH) is expected to report for Q2 2025 Investors Title Company (ITIC) is expected to report for Q2 2025 Safehold Inc. (SAFE) is expected to report $0.39 for Q2 2025 First Guaranty Bancshares Inc. (FGBI) is expected to report $-0.2 for Q2 2025 United Fire Group...